GLSI Earnings Greenwich LifeSciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.39 | 2026-06-04 | 10-Q |
| FY 2025 | 2025-12-31 | -1.43 | 2026-06-01 | 10-K |
| FY 2025 | 2025-09-30 | -0.76 | 2026-06-01 | 10-K |
| FY 2025 | 2025-06-30 | -0.49 | 2026-06-01 | 10-K |
| Q1 2026 | 2025-03-31 | -0.21 | 2026-06-04 | 10-Q |
| FY 2025 | 2024-12-31 | -1.34 | 2026-06-01 | 10-K |
| Q3 2025 | 2024-09-30 | -0.60 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.39 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.19 | 2025-05-20 | 10-Q |
| FY 2024 | 2023-12-31 | -0.69 | 2025-04-15 | 10-K |
| Q3 2024 | 2023-09-30 | -0.48 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.29 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.17 | 2024-05-20 | 10-Q |
| FY 2023 | 2022-12-31 | -0.61 | 2024-04-15 | 10-K |
| Q3 2023 | 2022-09-30 | -0.39 | 2023-10-19 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.21 | 2023-08-21 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.